| scholarly article | Q13442814 |
| P356 | DOI | 10.1034/J.1399-3046.2001.005004274.X |
| P698 | PubMed publication ID | 11472606 |
| P2093 | author name string | Balistreri WF | |
| Ryckman FC | |||
| Bucuvalas JC | |||
| Kotagal U | |||
| Krug S | |||
| Alonso MH | |||
| P2860 | cites work | Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells | Q33905168 |
| Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985) | Q34048790 | ||
| Portal and systemic haemodynamic action of N-acetylcysteine in patients with stable cirrhosis | Q34382095 | ||
| Anaphylactoid reaction to intravenous acetylcysteine associated with electrocardiographic abnormalities | Q36215636 | ||
| Molecular therapies for vascular diseases | Q40978349 | ||
| Modification of vascular responses in xenotransplantation: inflammation and apoptosis | Q41588785 | ||
| Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. NIDDK Liver Transplantation Database Group. | Q41648002 | ||
| Neonatal hemochromatosis: outcomes of pharmacologic and surgical therapies | Q41689692 | ||
| Predictors of the cost of liver transplantation | Q42674572 | ||
| Long-term results of pediatric liver transplantation: an analysis of 569 transplants | Q46048992 | ||
| Payer status, but not race, affects the cost of liver transplantation | Q46837160 | ||
| Gastric-outlet obstruction induced by prostaglandin therapy in neonates | Q68217213 | ||
| Treatment of primary liver graft nonfunction with prostaglandin E1 | Q69538675 | ||
| Prostaglandin E1 for the treatment of primary non-function of the donor organ in liver transplantation | Q70224393 | ||
| Impact of N-acetylcysteine on the hepatic microcirculation after orthotopic liver transplantation | Q71075866 | ||
| Prostaglandin E1 administration following orthotopic liver transplantation: a randomized prospective multicenter trial | Q71466333 | ||
| Intravenous N-acetylcysteine and lung glutathione of patients with pulmonary fibrosis and normals | Q72032587 | ||
| Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment | Q73034296 | ||
| N-acetylcysteine improves indocyanine green extraction and oxygen transport during hepatic dysfunction | Q73075610 | ||
| Efficacy of N-acetylcysteine as a hepatoprotective agent in liver transplantation: an experimental study | Q73278941 | ||
| The impact of surgical complications after liver transplantation on resource utilization | Q73802582 | ||
| Does N-acetylcysteine improve hemodynamics and graft function in liver transplantation? | Q74359379 | ||
| Early hepatocyte, endothelial, and bile duct cell injury after pediatric liver transplantation from cadaveric or living-related donors | Q74376189 | ||
| The efficacy of N-acetylcysteine as a hepatoprotective agent in liver transplantation | Q74779411 | ||
| Prostaglandin E1 analogs do not improve renal function among either transplant or nontransplant patients: no further trials required | Q77291247 | ||
| P433 | issue | 4 | |
| P921 | main subject | acetylcysteine | Q375613 |
| alprostadil | Q579348 | ||
| P304 | page(s) | 274-278 | |
| P577 | publication date | 2001-08-01 | |
| P1433 | published in | Pediatric Transplantation | Q7159217 |
| P1476 | title | Effect of treatment with prostaglandin E1 and N-acetylcysteine on pediatric liver transplant recipients: a single-center study | |
| P478 | volume | 5 |
| Q43818354 | Can reperfusion injury of the liver be prevented? Trying to improve on a good thing |
| Q38112166 | Current knowledge on oxidative stress in hepatic ischemia/reperfusion |
| Q37683804 | Current status of oxidative stress in pediatric liver transplantation |
| Q37829472 | Experimental and clinical evidence for modification of hepatic ischaemia-reperfusion injury by N-acetylcysteine during major liver surgery |
| Q94146610 | Hepatic ischemia-reperfusion injury in liver transplant setting: mechanisms and protective strategies |
| Q36875476 | N-acetylcysteine administration does not improve patient outcome after liver resection |
| Q37733072 | Nitric oxide and redox regulation in the liver: part II. Redox biology in pathologic hepatocytes and implications for intervention |
| Q24235333 | Prostaglandins for adult liver transplanted patients |
| Q42269032 | ROS homeostasis, a key determinant in liver ischemic-preconditioning. |
| Q42212732 | The Effect and Safety of Prostaglandin Administration in Pediatric Liver Transplantation |
Search more.